首页> 外文会议>Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics >Lingzhi-Candidate for an International Recognized Medicine
【24h】

Lingzhi-Candidate for an International Recognized Medicine

机译:灵芝国际公认药物候选人

获取原文
获取原文并翻译 | 示例

摘要

The ultimate goal for any medicine, regardless of orthodox or traditional, is the same; i. e., safely eliminate disease or disorder and to restore human body normal function whereas pharmacology might be the bridge for the missing link between these two different kinds of medicine. Although traditional Chinese medicine has been used for thousands of years, owing to the difference in environment and perception between the past and present, such kind of finished products should be validated scientifically and under control, particularly when they are mostly available over-the- counter. "Traditional or complementary medicine is victim of both uncritical enthusiasts and uninformed skeptics", citied by Dr. Yasuhiro Suzuki, WHO Executive Director for Health Technology and Pharmaceuticals at a press release for "WHO Traditional Medicine Strategy 2002~ 2005". "This strategy is intended to tap into real potential for people's health and well-being, while minimizing the risks of unproven or misused remedies. "Lingzhi (Ganoderma lucidum), a member of fungus family used in China for thousands of years, has shown anti-tumor and other immunological as well as cardio-vascular properties in vitro and animal studies. With the encouraging recognition from United Kingdom together with professionalism and ethic, more researches on its quality standard and dosage regimen will prompt Lingzhi to become a candidate for an international recognized medicine.
机译:无论是正统的还是传统的,任何药物的最终目标都是相同的。一世。例如,安全地消除疾病或病症并恢复人体正常功能,而药理学可能是这两种不同药物之间缺少联系的桥梁。尽管中药已经使用了数千年,但由于过去和现在之间在环境和认知上的差异,此类成品必须经过科学验证并受到控制,尤其是在大多数非处方药可用的情况下。 。世卫组织卫生技术和药品执行董事Yasuhiro Suzuki博士在“世卫组织2002〜2005年传统医学战略”新闻稿中引用“传统或补充医学是狂热爱好者和知情人士的受害者”。 “这种策略旨在挖掘人们的健康和福祉的真正潜力,同时最大程度地减少未经证实或滥用的药物的风险。”灵芝(灵芝)是中国数千年来在中国使用的真菌家族的成员,它已经表明在体外和动物研究中的抗肿瘤和其他免疫学以及心血管特性。随着英国的认可以及专业精神和职业道德,有关其质量标准和剂量方案的更多研究将促使灵芝成为国际公认药物的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号